NewsAAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyHealthDay.comMarch 6, 2026
NewsAAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for OsteoporosisHealthDay.comMarch 6, 2026
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based ChemoimmunotherapyMarch 6, 2026
NewsBenefits of RT After Breast-Conserving Surgery Only Seen Within 10 YearsHealthDay.comDecember 8, 2022
NewsPerianal Disease, Stricturing or Penetrating Behavior Tied to Crohn Disease OutcomesHealthDay.comDecember 8, 2022
